Diaceutics PLC (AIM:DXRX)
118.50
+0.98 (0.83%)
Jun 27, 2025, 4:35 PM GMT+1
Diaceutics Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 12.74 | 16.67 | 19.84 | 19.68 | 25.26 | Upgrade
|
Cash & Short-Term Investments | 12.74 | 16.67 | 19.84 | 19.68 | 25.26 | Upgrade
|
Cash Growth | -23.54% | -16.00% | 0.84% | -22.10% | 115.49% | Upgrade
|
Accounts Receivable | 14.81 | 9.83 | 8.37 | 7 | 5.34 | Upgrade
|
Other Receivables | 0.89 | 0.3 | 2.05 | 2.92 | 2.43 | Upgrade
|
Receivables | 15.7 | 10.13 | 10.43 | 9.92 | 7.78 | Upgrade
|
Prepaid Expenses | 1.08 | 1.24 | 0.63 | 0.43 | 0.59 | Upgrade
|
Other Current Assets | - | - | - | 0.04 | - | Upgrade
|
Total Current Assets | 29.53 | 28.04 | 30.9 | 30.06 | 33.62 | Upgrade
|
Property, Plant & Equipment | 1.68 | 1.9 | 2.09 | 2.13 | 0.24 | Upgrade
|
Other Intangible Assets | 15.41 | 15.26 | 15.04 | 12.61 | 8.94 | Upgrade
|
Long-Term Deferred Tax Assets | 2 | 1.14 | 0.05 | 0 | 0.3 | Upgrade
|
Long-Term Deferred Charges | - | - | 0.18 | 0.22 | 0.42 | Upgrade
|
Total Assets | 48.62 | 46.34 | 48.26 | 45.01 | 43.52 | Upgrade
|
Accounts Payable | 1.22 | 1.07 | 0.76 | 0.51 | 0.47 | Upgrade
|
Accrued Expenses | 5.05 | 2.26 | 2 | 1.31 | 1.58 | Upgrade
|
Short-Term Debt | - | - | - | 0.13 | 0.12 | Upgrade
|
Current Portion of Leases | 0.15 | 0.15 | 0.12 | 0.15 | - | Upgrade
|
Current Income Taxes Payable | 0.47 | 0.47 | 0.42 | 0.33 | 0.45 | Upgrade
|
Current Unearned Revenue | 0.34 | 0.41 | 0.41 | 0.21 | 0.3 | Upgrade
|
Other Current Liabilities | 0.54 | 0.04 | 0.04 | - | - | Upgrade
|
Total Current Liabilities | 7.77 | 4.38 | 3.75 | 2.63 | 2.92 | Upgrade
|
Long-Term Leases | 0.91 | 1.06 | 1.21 | 1.29 | - | Upgrade
|
Long-Term Deferred Tax Liabilities | - | 0.03 | 0.71 | 0.45 | 0.37 | Upgrade
|
Other Long-Term Liabilities | 0.09 | 0.09 | 0.08 | - | - | Upgrade
|
Total Liabilities | 8.76 | 5.56 | 5.74 | 4.36 | 3.28 | Upgrade
|
Common Stock | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | Upgrade
|
Additional Paid-In Capital | - | 37.13 | 37.13 | 36.86 | 36.86 | Upgrade
|
Retained Earnings | 40.63 | 4.04 | 5.34 | 4.08 | 3.19 | Upgrade
|
Treasury Stock | -0.31 | -0.31 | -0.26 | -0.17 | - | Upgrade
|
Comprehensive Income & Other | -0.63 | -0.24 | 0.14 | -0.3 | 0.02 | Upgrade
|
Shareholders' Equity | 39.86 | 40.79 | 42.51 | 40.65 | 40.24 | Upgrade
|
Total Liabilities & Equity | 48.62 | 46.34 | 48.26 | 45.01 | 43.52 | Upgrade
|
Total Debt | 1.06 | 1.21 | 1.33 | 1.56 | 0.12 | Upgrade
|
Net Cash (Debt) | 11.68 | 15.46 | 18.51 | 18.11 | 25.14 | Upgrade
|
Net Cash Growth | -24.43% | -16.48% | 2.20% | -27.94% | 116.47% | Upgrade
|
Net Cash Per Share | 0.14 | 0.18 | 0.22 | 0.21 | 0.32 | Upgrade
|
Filing Date Shares Outstanding | 84.52 | 84.25 | 84.26 | 83.94 | 84.07 | Upgrade
|
Total Common Shares Outstanding | 84.52 | 84.25 | 84.26 | 83.94 | 84.07 | Upgrade
|
Working Capital | 21.76 | 23.66 | 27.14 | 27.43 | 30.7 | Upgrade
|
Book Value Per Share | 0.47 | 0.48 | 0.50 | 0.48 | 0.48 | Upgrade
|
Tangible Book Value | 24.44 | 25.52 | 27.47 | 28.04 | 31.3 | Upgrade
|
Tangible Book Value Per Share | 0.29 | 0.30 | 0.33 | 0.33 | 0.37 | Upgrade
|
Machinery | 0.83 | 0.73 | 0.62 | 0.48 | 0.4 | Upgrade
|
Leasehold Improvements | 0.53 | 0.53 | 0.53 | 0.48 | - | Upgrade
|
Order Backlog | 24.93 | 26.52 | - | - | - | Upgrade
|
Updated Sep 17, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.